Impact of Pycnogenol® on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice

Cardiovascular Toxicology

Volumn 7, Issue 1, 2007, Pages 10-18

  Zibadi, Sherma ^a   Yu, Qianli ^b   Rohdewald, Peter J ^c   Larson, Douglas F ^b   Watson, Ronald Ross ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cardiac function; Collagen; Extracellular matrix

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PYCNOGENOL; COLLAGEN; CROSS LINKING REAGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; FLAVONOID; MATRIX METALLOPROTEINASE; PYCNOGENOLS; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CROSS LINKING; DIET SUPPLEMENTATION; DOSE RESPONSE; EXTRACELLULAR MATRIX; GENE ACTIVITY; GENE EXPRESSION; HEART FUNCTION; HEART VENTRICLE FUNCTION; HEMODYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; ZYMOGRAPHY; AGING; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; C57BL MOUSE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

AGING; ANIMALS; BLOOD PRESSURE; COLLAGEN; CROSS-LINKING REAGENTS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FLAVONOIDS; HEART; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VENTRICULAR REMODELING;

EID: 34548331134     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-007-0001-9     Document Type: Article

References (42)

1. Araghi-Niknam, M., Hosseini, S., Larson, D., Rohdewald, P., & Watson, R. R. (2000). Pine bark extract reduces platelet aggregation. Integrative Medicine: Integrating Conventional and Alternative Medicine, 2, 73-77.
2. Barnes, P. J., & Larin, M. (1997). Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine, 336, 1066-1071.
3. Belch, J. J. F., Bridges, A. B., Scott, N., & Chopra, M. (1991). Oxygen free-radicals and congestive-heart-failure. British Heart Journal, 65, 245-248.
4. Bernatova, I., Pechanova, O., Pelouch, V., & Simko, F. (2000). Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: Effect of captopril. Journal of Molecular and Cellular Cardiology, 32, 177-185.
5. Blazso, G., Gaspar, R., Gábor, M., Rüve, H. J., & Rohdewald, P. (1996). ACE inhibition and hypotensive effect of procyanidins-containing extract from the bark of Pinus pinaster sol. Pharmacy Pharmacology Letters, 6, 8-11.
6. Bozkurt, B., Kribbs, S. B., Clubb, F. J., Michael, L. H., Didenko, V. V., Hornsby, P. J., Seta, Y., Oral, H., Spinale, F. G., & Mann, D. L. (1998). Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 97, 1382-1391.
7. Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998). Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation, 97, 1375-1381.
8. Cheshier, J. E., ArdestaniKaboudanian, S., Liang, B. L., Araghiniknam, M., Chung, S. B., Lane, L., Castro, A., & Watson, R. R. (1995). Immunomodulation by Pycnogenol (R) in retrovirus-infected or ethanol-fed mice. Life Sciences, 58, L87-L96.
9. Chiariello, M., Ambrosio, G., Cappelli-Bigazzi, M., Perrone-Filardi, P., Brigante, F., & Sifola, C. (1986). A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. Journal of Molecular and Cellular Cardiology, 18, 283-290.
10. Cohn, J. N., Ferrari, R., & Sharpe, N. (2000). Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Journal of the American College of Cardiology, 35, 569-582.
11. Devaraj, S., Vega-Lopez, S., Kaul, N., Schonlau, F., Rohdewald, P., & Jialal, I. (2002). Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids, 37, 931-934.
12. Dhalla, A. K., Hill, M. F., & Singal, P. K. (1996). Role of oxidative stress in transition of hypertrophy to heart failure. Journal of the American College of Cardiology, 28, 506-514.
13. Droge, W., Mihm, S., Bockstette, M., & Roth, S. (1994). Effect of reactive oxygen intermediates and antioxidants on proliferation and function of T-lymphocytes. Methods in Enzymology, 234, 135-151.
14. Duarte, J., Jimenez, R., O'Valle, F., Galisteo, M., Perez-Palencia, R., Vargas, F., Perez-Vizcaino, F., Zarzuelo, A., & Tamargo, J. (2002). Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. Journal of Hypertension, 20, 1843-1854.
15. Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R. K. (2005). Cardiac remodeling and failure - From molecules to man (Part II). Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology, 14, 49-60.
16. Fitzpatrick, D. F., Bing, B., & Rohdewald, P. (1998). Endothelium-dependent vascular effects of Pycnogenol. Journal of Cardiovascular Pharmacology, 32, 509-515.
17. Grimm, T., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., & Hogger, P. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). Journal of Inflammation (London), 3, 1, 2006 [Epub ahead of print].
18. Grimm, T., Schafer, A., & Hogger, P. (2004). Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radical Biology & Medicine, 36, 811-822.
19. Gunja-Smith, Z., Morales, A. R., Romanelli, R., & Woessner, J. F. (1996). Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy - Role of metalloproteinases and pyridinoline cross-links. American Journal of Pathology, 148, 1639-1648.
20. Hosseini, S., Lee, J., Sepulveda, R. T., Rohdewald, P., & Watson, R. R. (2001). A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutrient Research, 21, 1251-1260.
21. Kim, H. E., Dalal, S. S., Young, E., Legato, M. J., Weisfeldt, M. L., & D'Armiento, J. (2000). Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. The Journal of Clinical Investigation, 106, 857-866.
22. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998). Elevated levels of 8-iso-prostaglandin F-2 alpha in pericardial fluid of patients with heart failure - A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation, 97, 1536-1539.
23. Matsunaga, T., Weihrauch, D. W., Moniz, M. C., Tessmer, J., Warltier, D. C., & Chilian, W. M. (2002). Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation, 105, 2185-2191.
24. Nakamura, K., Kusano, K., Nakamura, Y., Kakishita, M., Ohta, K., Nagase, S., Yamamoto, M., Miyaji, K., Saito, H., Morita, H., Emori, T., Matsubara, H., Toyokuni, S., & Ohe, T. (2002). Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation, 105, 2867-2871.
25. Nelson, K. K., & Melendez, J. A. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radical Biology & Medicine, 37, 768-784.
26. Packer, L., Rimbach, G., & Virgili, F. (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from the pine (Pinus maritima) bark, Pycnogenol. Free Radical Biology & Medicine, 27, 704-724.
27. Paulus, W. J. (2000). Cytokines and heart failure. Heart Failure Monitor, 1, 50-56.
28. Peterson, J. T., Hallak, H., Johnson, L., Li, H., O'Brien, P. M., Sliskovic, D. R., Bocan, T. M. A., Coker, M. L., Etoh, T., & Spinale, F. G. (2001). Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation, 103, 2303-2309.
29. Rohdewald, P. J. (2005). Pycnogenol®, French maritime pine bark extract. In P. Coates, MR Blackman, G Cragg, M Levine, J Moss, & J. White (Eds.), Encyclopedia of dietary supplements (pp. 545-553). New York: Marcel Dekker.
30. Schafer, A., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., & Hogger, P. (2006). Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomedicine & Pharmacotherapy, 60, 5-9.
31. Spinale, F. G. (2004). Matrix metalloproteinase gene polymorphisms in heart failure: New pieces to the myocardial matrix puzzle. European Heart Journal, 25, 631-633.
32. Stegeman, H., & Stalder, K. (1967). Determination of Hydroxyproline. Clinica Chimica Acta; International Journal of Clinical Chemistry, 18, 267-273.
33. Testa, M., Yeh, M., Lee, P., Fanelli, R., Loperfido, F., Berman, J. W., & LeJemtel, T. H. (1996). Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. Journal of the American College of Cardiology, 28, 964-971.
34. Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998). Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation, 97, 1708-1715.
35. TorreAmione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996). Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology, 27, 1201-1206.
36. Vincenti, M. P., & Brinckerhoff, C. E. (2002). Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Research, 4, 157-164. Review.
37. Wang, S., Tan, D., Zhao, Y., Gao, G., Gao, X., & Hu, L. (1999). The effect of Pycnogenol on the microcirculation, platelet function and ischemic myocardium in patients with coronary artery disease. European Bulletin of Drug Research, 7, 19-25.
38. Wang, W. J., Viappiani, S., Sawicka, J., & Schulz, R. (2005). Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release. British Journal of Pharmacology, 145, 43-49.
39. Woodiwiss, A. J., Tsotetsi, O. J., Sprott, S., Lancaster, E. J., Mela, T., Chung, E. S., Meyer, T. E., & Norton, G. R. (2001). Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation, 103, 155-160.
40. Yang, B., Larson, D. F., Kelley, R., Beischel, J., & Watson, R. R. (2000). Conductivity: An issue for the application of the conductance catheter system in mice. Cardiovascular Engineering, 5, 57-60.
41. Yang, B., Larson, D. F., & Watson, R. (1999). Age-related left ventricular function in the mouse: Analysis based on in vivo pressure-volume relationships. American Journal of Physiology. Heart and Circulatory Physiology, 277, H1906-H1913.
42. Yu, Q., Larson, D. F., Slayback, D., Lundeen, T., Baxter, J. H., & Watson, R. R. (2004). Characterization of high salt and high fat diets on cardiac and vascular function in mice. Cardiovascular Toxicology, 4, 37-46.